NuVasive Launches Reline Cervical for Posterior Cervical Fusion

NuVasive Inc. has officially launched Reline Cervical, a new fixation system for posterior cervical fusion (PCF) in targeted regions.
 
“Reline Cervical completes the foundational three strategic pillars of C360—anterior cervical decompression and fusion, cervical total disc replacement, and now PCF. This launch is a significant step forward for our fixation portfolio and furthers our goal of becoming the market leader in complex deformity while extending our position with the industry’s leading cervical portfolio,” said Ryan Donahoe, chief technology officer at NuVasive. “We have leveraged our expertise with the proven Reline system, combined with Pulse®, to deliver our best PCF solution. The key advancements in this procedural technology fuel continued growth and differentiation in the cervical spine segment.”
 
As cervical spine procedures comprise an approximately $2.6 billion subsegment of the global spine market, the introduction of Reline Cervical will allow the company’s C360 portfolio to potentially capture more market share. Surgeons can address complex PCF surgeries within one comprehensive fixation portfolio, as well as utilize the enabling technologies within Pulse. The compatibility of Reline Cervical with Pulse gives surgeons the benefits of navigation, imaging enhancement, intraoperative neuromonitoring, iGA®, and patient-specific rod bending.
 
“The Reline Cervical design is best-in-class. I’m impressed by the screw range, great connector options, and the full junctional offering, helping me address the varying complex deformity cases I see in my practice,” said Steven Ludwig, M.D., orthopedic spine surgeon at the University of Maryland. “Having the benefits of the thoracolumbar Reline system now in the cervical spine gives me confidence that I’m giving my patients the best solution.”
 
The expansion of the C360 portfolio further supports a comprehensive anterior and posterior offering of instrumentation, implants, biologic materials, and enabling technologies for any cervical procedure.
 
NuVasive Inc.’s less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The company’s procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients.